These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 12534327)
1. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions. Leone R; Venegoni M; Motola D; Moretti U; Piazzetta V; Cocci A; Resi D; Mozzo F; Velo G; Burzilleri L; Montanaro N; Conforti A Drug Saf; 2003; 26(2):109-20. PubMed ID: 12534327 [TBL] [Abstract][Full Text] [Related]
2. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Lapi F; Tuccori M; Motola D; Pugi A; Vietri M; Montanaro N; Vaccheri A; Leoni O; Cocci A; Leone R; Conforti A; Moretti U; Sessa E; Mazzaglia G; Mugelli A; Mazzei T; Vannacci A Drug Saf; 2010 Sep; 33(9):789-99. PubMed ID: 20701411 [TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Sachs B; Riegel S; Seebeck J; Beier R; Schichler D; Barger A; Merk HF; Erdmann S Drug Saf; 2006; 29(11):1087-100. PubMed ID: 17061914 [TBL] [Abstract][Full Text] [Related]
4. Use and safety profile of antiepileptic drugs in Italy. Iorio ML; Moretti U; Colcera S; Magro L; Meneghelli I; Motola D; Rivolta AL; Salvo F; Velo GP Eur J Clin Pharmacol; 2007 Apr; 63(4):409-15. PubMed ID: 17347806 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506 [TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Conforti A; Leone R; Moretti U; Mozzo F; Velo G Drug Saf; 2001; 24(14):1081-90. PubMed ID: 11735663 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Naldi L; Conforti A; Venegoni M; Troncon MG; Caputi A; Ghiotto E; Cocci A; Moretti U; Velo G; Leone R Br J Clin Pharmacol; 1999 Dec; 48(6):839-46. PubMed ID: 10594488 [TBL] [Abstract][Full Text] [Related]
8. Comparison of side effects of levofloxacin versus other fluoroquinolones. Carbon C Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784 [TBL] [Abstract][Full Text] [Related]
9. Drug-related deaths: an analysis of the Italian spontaneous reporting database. Leone R; Sottosanti L; Luisa Iorio M; Santuccio C; Conforti A; Sabatini V; Moretti U; Venegoni M Drug Saf; 2008; 31(8):703-13. PubMed ID: 18636789 [TBL] [Abstract][Full Text] [Related]
10. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile. Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453 [TBL] [Abstract][Full Text] [Related]
11. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy. Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462 [TBL] [Abstract][Full Text] [Related]
12. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L; Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions. Bonaldo G; Andriani LA; D'Annibali O; Motola D; Vaccheri A Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1457-1463. PubMed ID: 31423694 [TBL] [Abstract][Full Text] [Related]
14. Comparative tolerability of the newer fluoroquinolone antibacterials. Ball P; Mandell L; Niki Y; Tillotson G Drug Saf; 1999 Nov; 21(5):407-21. PubMed ID: 10554054 [TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions to fluoroquinolones at a tertiary care hospital in northern India. Uppal R; Jhaj R; Malhotra S J Assoc Physicians India; 1998 Nov; 46(11):946-7. PubMed ID: 11229222 [TBL] [Abstract][Full Text] [Related]
17. A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders. Huruba M; Farcas A; Leucuta DC; Bucsa C; Sipos M; Mogosan C Sci Rep; 2021 Jul; 11(1):14375. PubMed ID: 34257376 [TBL] [Abstract][Full Text] [Related]
18. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. van der Linden PD; van Puijenbroek EP; Feenstra J; Veld BA; Sturkenboom MC; Herings RM; Leufkens HG; Stricker BH Arthritis Rheum; 2001 Jun; 45(3):235-9. PubMed ID: 11409663 [TBL] [Abstract][Full Text] [Related]
19. A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects. Hayem G; Carbon C Drug Saf; 1995 Dec; 13(6):338-42. PubMed ID: 8652078 [TBL] [Abstract][Full Text] [Related]